Waseem Hajjar | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Waseem Hajjar — King Saud University, Saudi Arabia

Researcher Profile
Researcher Waseem Hajjar
Affiliation King Saud University
Country Saudi Arabia
Scopus ID 35518559800
Documents 76
Citations 1,154
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0001-7916-972X

Waseem Hajjar is a researcher affiliated with King Saud University, Saudi Arabia. The supplied academic profile identifies 76 documents, 1,154 citations, and an h-index of 17. His scholarly identity is additionally represented through persistent ORCID, Scopus, and Google Scholar profiles. The Innovative Research Award profile presented here summarizes the supplied bibliometric and institutional information in a neutral academic format.

Abstract

Waseem Hajjar is a clinical medicine researcher affiliated with King Saud University, Saudi Arabia, whose scholarly record includes 76 indexed documents, 1,154 citations, and an h-index of 17 according to the supplied profile data. His research portfolio reflects sustained engagement with clinical research and scholarly communication. The Innovative Research Award profile recognizes his documented research activity, publication record, citation impact, and professional presence across academic platforms. His ORCID, Scopus, and Google Scholar identifiers provide persistent links for verification and facilitate discovery of his scholarly contributions. This page summarizes the supplied academic information and presents it in a neutral format internationally.

Keywords

Clinical medicine; clinical research; medical research; healthcare research; evidence-based medicine; biomedical research; academic publishing; research collaboration; scholarly communication; research impact; citation analysis; Scopus; ORCID; Google Scholar; King Saud University; Saudi Arabia; innovative research; medical science; health sciences.

Introduction

Waseem Hajjar’s academic profile is presented within the context of clinical medicine and scholarly research. The supplied information identifies King Saud University as his institutional affiliation and Saudi Arabia as his country. Bibliometric indicators provide a concise description of indexed research activity, while persistent identifiers enable readers to distinguish and verify the researcher’s scholarly record across major academic platforms. Scopus provides author-level indexing and citation information, whereas ORCID supplies a persistent researcher identifier.

Research Profile

Waseem Hajjar is affiliated with King Saud University in Saudi Arabia and is identified in Scopus by author ID 35518559800. The supplied profile records 76 documents, 1,154 citations, and an h-index of 17. His identifiers across Scopus and ORCID support consistent attribution and scholarly profile discovery within academic databases internationally. These platforms provide complementary approaches to discovering publications, citations, author identifiers, and scholarly outputs. Bibliographic databases may differ in coverage and indexing practices, so individual records should be consulted when precise publication-level information is required. [1]

Research Contributions

Waseem Hajjar’s research contributions can be described through documented publication activity in clinical medicine and the associated citation record. Metrics indicate sustained scholarly output rather than one contribution. Interpretation of research themes should rely on individual publications, methodologies, findings, clinical contexts, and independently documented evidence from relevant literature and sources. Assessment of clinical research contributions generally requires consideration of study design, methodological rigor, reproducibility, clinical relevance, and the extent to which findings contribute to established knowledge.  [2]

Publications

Waseem Hajjar’s publication record contains 76 documents in the supplied Scopus profile. These publications provide evidence to evaluate research themes, methods, collaborations, and clinical relevance. Because publication titles and bibliographic details were not supplied here, this section avoids assigning topics and instead directs readers to the author record for verification. The supplied document count should be understood as a database-specific indicator rather than a complete inventory of every scholarly output.  [1]

Research Impact

Waseem Hajjar’s supplied citation indicators include 1,154 citations and an h-index of 17. These measures provide quantitative descriptions of scholarly visibility within the indexed record, while interpretation depends on field, publication age, database coverage, collaboration patterns, and citation practices. They should therefore be considered alongside publication-level evidence and contextual assessment. Citation indicators are commonly used to describe patterns of scholarly attention, but they have recognized limitations. [3]

Award Suitability

Waseem Hajjar’s profile contains identifiable academic credentials, indexed publications, citation indicators, and persistent researcher identifiers relevant to consideration for an Innovative Research Award. Award suitability should be determined from documented evidence, including originality, methodological quality, research contribution, reproducibility, and relevance of individual studies, rather than from bibliometric indicators alone. For a comprehensive award assessment, individual publications and supporting evidence should be reviewed alongside the supplied profile information. [4]

Conclusion

Waseem Hajjar’s supplied academic profile documents an affiliation with King Saud University, a Scopus author record containing 76 documents, 1,154 citations, and an h-index of 17, together with persistent ORCID and Google Scholar identifiers. These details provide a structured overview of scholarly activity. More detailed evaluation should be based on the underlying publications and independently verifiable research evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Waseem Hajjar, Author ID 35518559800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35518559800
  2. ORCID. (n.d.). Waseem Hajjar — ORCID record.
    https://orcid.org/0000-0001-7916-972X
  3. Kaaki, S., Barnawi, A. B., Robaidi, H. A., Maghrabi, A. A., Almaymuni, A. D., Alzahim, A., Almahmoud, A., Alsalem, K. A., Alshehri, Y. M., Alsharari, H. S., & Hajjar, W. M. (2026). Perioperative outcomes and safety of uniportal robotic-assisted thoracic surgery (U-RATS) for anatomic lung resection: A systematic review and meta-analysis. https://link.springer.com/article/10.1007/s11701-026-03349-x
  4. Health Scientists Awards. (n.d.). Health Scientists Awards.
    https://healthscientists.org/
  5. Google Scholar. (n.d.). Waseem Hajjar — Google Scholar profile.
    https://scholar.google.com/citations?user=7s7wbfUAAAAJ&hl=en&oi=ao

Jaehoon Lee | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Jaehoon Lee
Affiliation Clinical Medicine; vascular and endovascular surgery
Country South Korea
Google Scholar View Profile
Documents 25
Citations 155
h-index 8
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0906-5236

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Abstract

Jaehoon Lee is a South Korean clinical medicine researcher whose documented work focuses on vascular and endovascular surgery. His publications address endovascular aneurysm repair, peripheral arterial disease, femorofemoral bypass, arteriovenous access thrombosis, and emerging procedural approaches. The research emphasizes anatomical assessment, graft performance, procedural feasibility, postoperative complications, and clinical outcomes. His studies include retrospective analyses, case-based investigations, and multicenter prospective research, reflecting an applied approach to vascular care. The publication record demonstrates sustained interest in improving revascularization strategies, evaluating vascular devices, and identifying factors associated with treatment outcomes. These contributions support consideration for an Innovative Research Award in Clinical Medicine.

Keywords

Vascular surgery; endovascular surgery; peripheral arterial disease; endovascular aneurysm repair; abdominal aortic aneurysm; femorofemoral bypass; saphenous vein graft; polytetrafluoroethylene; vascular access; arteriovenous fistula; thrombosis; rotational atherectomy; infrainguinal arterial disease; revascularization; graft patency; iliac branch device; arterial anatomy; vascular devices; clinical outcomes; postoperative complications; predictive modeling; machine learning; atherosclerosis; clinical medicine.

Introduction

Jaehoon Lee is a South Korean clinician-researcher working in vascular and endovascular surgery within clinical medicine. His documented publications address peripheral arterial disease, endovascular aneurysm repair, vascular access, arterial reconstruction, and device-based interventions. His work combines clinical outcomes, procedural evaluation, imaging, and statistical analysis to examine practical vascular treatment strategies. [1]

Research Profile

Jaehoon Lee’s research profile centers on vascular and endovascular surgery, with publications involving abdominal aortic aneurysm repair, femorofemoral bypass, arteriovenous access, and infrainguinal arterial disease. His documented work reflects clinically oriented investigation, retrospective and multicenter study designs, procedural assessment, and evaluation of anatomical or treatment factors affecting outcomes today broadly. [2]

Research Contributions

Jaehoon Lee has contributed to clinical vascular research through studies evaluating endovascular aneurysm repair, graft selection, vascular access thrombosis, and contemporary peripheral interventions. His publications examine technical feasibility, anatomical change, graft patency, postoperative complications, and longer-term clinical outcomes, providing evidence relevant to decision-making in vascular surgery practice and patient care. [3]

Publications

Jaehoon Lee’s documented publication record includes research on changes following endovascular aneurysm repair, custom-made iliac branch devices, femorofemoral bypass graft selection, postoperative thrombosis of arteriovenous access, and predictive modeling of arteriovenous fistula occlusion. Recent multicenter research also examines rotational atherectomy with antirestenotic therapy for infrainguinal arterial disease. [1] [2]

Research Impact

Jaehoon Lee’s research has clinical relevance because vascular diseases require durable revascularization, careful anatomical assessment, and management of procedure-related complications. His studies address these needs through outcome-oriented analyses of bypass grafts, endovascular repair, dialysis access, and peripheral arterial interventions, supporting evidence-based refinement of vascular surgical and endovascular practice clinically directly. [3] [4]

Award Suitability

Jaehoon Lee demonstrates a research portfolio aligned with Innovative Research Award consideration in Clinical Medicine, particularly vascular and endovascular surgery. His documented studies investigate procedural strategies, device applications, graft alternatives, predictive modeling, and multicenter peripheral arterial treatment. The portfolio shows sustained clinical investigation and practical relevance to contemporary vascular care.[5]

Conclusion

Jaehoon Lee’s documented research demonstrates a consistent clinical focus on vascular and endovascular medicine, spanning aneurysm repair, peripheral arterial disease, bypass surgery, vascular access, and procedural innovation. The available publication record supports recognition of a clinically relevant research program that connects technical investigation with patient-centered outcomes and evolving vascular practice.[4]

References

  1. Lee JH, Park KH, Kwak SG. Changes in Neck Angle, Neck Length, Maximum Diameter, Maximum Area and Thrombus after Endovascular Aneurysm Repair. Vascular Specialist International. https://doi.org/10.5758/vsi.190054
  2. Park YE, Lee JH, Yun WS, Park KH. Surgeon custom-made iliac branch device to salvage hypogastric artery during endovascular aneurysm repair. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2014.29.12.1678
  3. Kwon G, Park KH, Kwak SG, Lee JH. The Results of Femorofemoral Bypass Using a Saphenous Vein Graft as an Alternative to PTFE Grafts. Vascular Specialist International. https://doi.org/10.5758/vsi.220060
  4. Kim J, Park K, Cho Y, Lee J. The Effects of Vasodilation Induced by Brachial Plexus Block on the Development of Postoperative Thrombosis of the Arteriovenous Access in Patients with End-Stage Renal Disease: A Retrospective Study. International Journal of Environmental Research and Public Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC9690458/
  5. Lee JH, Kwak SG. Development of a Machine Learning-Based Predictive Model for Arteriovenous Fistula Occlusion After Surgery: A Retrospective Cohort Study from 2015 to 2025. Medicina. https://doi.org/10.3390/medicina61122150

Bernd Fink | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Bernd Fink
Affiliation Orthopaedic Clinic Markgröningen
Country Germany
Scopus ID 22943409800
Documents 176
Citations 3,339
h-index 29
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-7485-3941
Bernd Fink – Orthopaedic Clinic Markgröningen, Germany

Bernd Fink is a German orthopaedic surgeon and clinical researcher whose scholarly work primarily focuses on hip and knee arthroplasty, implant fixation, revision surgery, prosthetic joint infection, and long-term orthopedic outcomes. His scientific publications have contributed to improving evidence-based clinical practice through investigations into implant performance, surgical techniques, and patient-centered treatment strategies. His academic profile reflects sustained engagement with musculoskeletal research and international collaboration within clinical medicine.[1]

Abstract

Bernd Fink has established an internationally recognized academic profile through clinical investigations involving hip arthroplasty, knee replacement, implant fixation, revision procedures, prosthetic joint infection, biomaterials, and orthopedic outcomes. His publications emphasize evidence-based surgical decision-making, implant longevity, patient safety, and postoperative functional recovery. By integrating clinical observations with long-term follow-up studies, his research supports improvements in orthopedic practice and healthcare quality. His contributions continue influencing musculoskeletal surgery through scientifically validated findings that benefit clinicians, researchers, and patients while strengthening international orthopedic literature and advancing modern clinical medicine through collaborative multidisciplinary research worldwide.[2]

Keywords

Hip Arthroplasty, Knee Arthroplasty, Revision Arthroplasty, Prosthetic Joint Infection, Cementless Implant, Implant Fixation, Acetabular Cup, Femoral Stem, Orthopaedic Surgery, Clinical Outcomes, Total Hip Replacement, Joint Reconstruction.

Introduction

Bernd Fink investigates orthopedic surgery through clinically relevant research addressing joint replacement, revision strategies, implant fixation, infection prevention, and long-term patient outcomes. His scholarly publications integrate practical surgical experience with scientific evaluation, supporting evidence-based improvements in musculoskeletal healthcare while strengthening contemporary orthopedic knowledge through internationally recognized clinical investigations.[1]

Research Profile

Bernd Fink maintains an active research profile centered on hip arthroplasty, knee replacement surgery, prosthetic joint infection, implant survival, revision procedures, and orthopedic biomechanics. His publications demonstrate sustained collaboration with international researchers while contributing valuable clinical evidence supporting safer surgical interventions and improved patient rehabilitation across orthopedic practice.[2]

Research Contributions

Bernd Fink contributes significantly by evaluating implant performance, optimizing revision arthroplasty techniques, investigating prosthetic infections, and improving postoperative recovery through evidence-based orthopedic studies. His findings assist clinicians in selecting effective surgical approaches while promoting durable implant performance and enhanced quality of patient-centered musculoskeletal healthcare internationally.[3]

Publications

Bernd Fink has published extensively on hip arthroplasty, knee replacement, prosthetic joint infection, implant fixation, revision surgery, and long-term orthopedic outcomes. His scholarly articles emphasize evidence-based surgical practice, implant longevity, patient recovery, and clinical decision-making, providing valuable scientific knowledge that supports continuous advancements in modern orthopedic medicine worldwide.[3]

Research Impact

Bernd Fink’s research provides clinically meaningful evidence supporting orthopedic surgeons managing complex arthroplasty cases. His publications strengthen understanding of implant longevity, revision surgery, prosthetic infection prevention, and postoperative rehabilitation. These scholarly contributions continue supporting healthcare professionals seeking reliable evidence for improving orthopedic surgical quality and patient outcomes.[4]

Award Suitability

Bernd Fink demonstrates qualities consistent with recognition through the Innovative Research Award because his sustained orthopedic investigations have strengthened evidence-based clinical medicine. His scholarly contributions, publication record, international visibility, and commitment to improving arthroplasty outcomes collectively reflect meaningful scientific achievement deserving academic recognition within contemporary health sciences.[4]

Conclusion

Bernd Fink continues contributing valuable scientific knowledge through orthopedic clinical research emphasizing implant performance, revision surgery, infection management, and patient outcomes. His publications support evidence-based healthcare while promoting continuous improvements in musculoskeletal medicine. His academic achievements illustrate a sustained commitment to advancing clinical medicine through rigorous scientific investigation.[2]

References

  1. Scopus Author Profile. Bernd Fink.
    https://www.scopus.com/authid/detail.uri?authorId=22943409800
  2. ORCID. Bernd Fink Research Profile.
    https://orcid.org/0000-0002-7485-3941
  3. Fink, B., & Tetsworth, K. D. (2017). Antibiotic elution from cement spacers and its influencing factors.
    https://doi.org/10.3390/antibiotics14070705
  4. ResearchGate Profile.
    https://www.researchgate.net/profile/Bernd-Fink-3
  5. Health Scientists Awards.
    https://healthscientists.org/

Sarfaraz Niazi | Clinical Medicine | Lifetime Achievement Award

Published on by Health Scientists

Lifetime Achievement Award

Sarfaraz Niazi
Affiliation Washington State University
Country United States
Scopus ID 7004749563
Documents 156
Citations
2,572
h-index 26
Subject Area Clinical Medicine
Event Health Scientists Awards
ORCID 0000-0002-0513-0336

Sarfaraz Niazi
Washington State University, United States

Sarfaraz Niazi is an internationally recognized pharmaceutical scientist whose scholarly work has significantly influenced pharmaceutical formulation science, manufacturing technologies, dosage form development, drug delivery systems, regulatory sciences, and pharmaceutical product commercialization. His publications, technical handbooks, and scientific contributions have been extensively utilized by academic researchers, pharmaceutical industries, regulatory professionals, and healthcare innovators worldwide. His sustained research productivity, educational publications, and practical innovations demonstrate long-term contributions to clinical medicine and pharmaceutical sciences deserving scholarly recognition.[1]

Abstract

Sarfaraz Niazi has established a distinguished academic career through influential research, authoritative pharmaceutical reference books, and practical innovations supporting drug formulation, pharmaceutical manufacturing, analytical development, quality assurance, and commercialization. His scholarly publications have contributed to improving pharmaceutical education, industrial manufacturing practices, regulatory understanding, and formulation science across diverse healthcare applications. The breadth of his scientific output, sustained international citation record, and educational influence demonstrate enduring contributions to clinical medicine and pharmaceutical sciences while supporting innovation, professional training, and evidence-based pharmaceutical development worldwide.[2]

Keywords

Pharmaceutical formulation, Drug delivery, Pharmaceutical manufacturing, Dosage forms, Preformulation, Drug development, Regulatory science, Clinical medicine, Pharmaceutical technology, Quality assurance, Drug discovery, Formulation development.

Introduction

Sarfaraz Niazi has contributed extensively to pharmaceutical sciences through multidisciplinary research integrating formulation development, manufacturing technologies, analytical methodologies, and industrial pharmaceutical practice. His scientific publications and reference books continue supporting researchers, educators, pharmaceutical manufacturers, and healthcare professionals seeking evidence-based approaches for modern pharmaceutical product development and commercialization.[3]

Research Profile

Sarfaraz Niazi has maintained an internationally recognized scholarly profile characterized by influential publications, comprehensive pharmaceutical textbooks, industrial expertise, and sustained academic engagement. His research spans pharmaceutical manufacturing, formulation optimization, regulatory sciences, dosage form technologies, and translational pharmaceutical innovation supporting healthcare advancement through scientific excellence.[1]

Research Contributions

Sarfaraz Niazi has advanced pharmaceutical sciences by developing authoritative resources addressing formulation strategies, manufacturing processes, quality systems, and commercialization pathways. His publications bridge academic knowledge with industrial implementation, strengthening pharmaceutical education while facilitating innovation in drug development, product quality, and therapeutic manufacturing technologies worldwide.[4]

Publications

Sarfaraz Niazi has authored influential books and peer-reviewed publications covering pharmaceutical preformulation, liquid dosage manufacturing, computer-aided drug discovery, pharmaceutical technologies, and industrial formulation sciences. These scholarly resources remain widely referenced within universities, pharmaceutical industries, regulatory organizations, and professional research environments internationally.[5]

Research Impact

Sarfaraz Niazi has generated enduring academic and industrial influence through publications supporting pharmaceutical innovation, formulation optimization, manufacturing quality, and educational advancement. His scholarly contributions continue assisting researchers and healthcare industries in developing effective pharmaceutical products while strengthening evidence-based pharmaceutical sciences internationally.[2]

Award Suitability

Sarfaraz Niazi demonstrates sustained scholarly excellence through influential research publications, internationally recognized pharmaceutical references, educational leadership, and practical industrial innovation. These long-term scientific achievements, combined with substantial global academic influence, strongly align with the objectives and recognition standards associated with the Lifetime Achievement Award.[1]

Conclusion

Sarfaraz Niazi has built an internationally respected scientific legacy through pharmaceutical research, industrial innovation, educational scholarship, and authoritative publications. His lasting influence across pharmaceutical sciences, clinical medicine, formulation technology, and healthcare education reflects the sustained excellence expected from recipients of distinguished international scientific recognition.[5]

References

  1. Elsevier. (n.d.). Scopus author details: Sarfaraz Niazi, Author ID 7004749563. Scopus.
    https://www.scopus.com/pages/authors/7004749563
  2. ORCID. (n.d.). Sarfaraz Niazi ORCID Record.
    https://orcid.org/0000-0002-0513-0336
  3. Google Scholar. (n.d.). Scholar Profile: Sarfaraz Niazi.
    https://scholar.google.com/citations?user=O2dgTYIAAAAJ&hl=en&oi=ao
  4. ResearchGate. (n.d.). Sarfaraz Niazi Research Profile.
    https://www.researchgate.net/profile/Sarfaraz-Niazi-3
  5. Niazi, S. K., & Mariam, Z. (2024). Computer-aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals.
    https://doi.org/10.3390/ph17010022

Konstantin Konstantinov | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Konstantin Konstantinov
Researcher Konstantin Konstantinov
Affiliation University of New Mexico
Country United States
Scopus ID 55808069944
Documents 38
Citations
2,384
h-index 17
Subject Area Clinical Medicine
Event Health Scientists Awards

Konstantin Konstantinov
University of New Mexico

Konstantin Konstantinov, affiliated with the University of New Mexico, is a researcher in Clinical Medicine whose scholarly work contributes to advancing evidence-based biomedical research. His publications indexed in Scopus demonstrate sustained engagement with clinically relevant investigations, interdisciplinary collaboration, and scientific dissemination. This recognition article summarizes his research profile, scholarly contributions, publication themes, research impact, and suitability for the Health Scientists Awards, based on publicly available academic records and recognized scholarly databases.[1]

Abstract

Konstantin Konstantinov has established an academic profile within Clinical Medicine through scholarly publications emphasizing translational biomedical research, disease mechanisms, diagnostic innovation, clinical applications, and collaborative investigation. His work reflects sustained participation in internationally indexed research while contributing to evidence-based healthcare knowledge. Publications demonstrate methodological rigor, scientific relevance, and interdisciplinary cooperation across medical sciences. Indexed visibility through Scopus and ORCID supports transparent scholarly communication and research accessibility. Collectively, these achievements indicate meaningful engagement with contemporary clinical research and provide a credible foundation for recognition through international academic awards dedicated to advancing health sciences and biomedical innovation.[1][2]

Keywords

Clinical Medicine, Biomedical Research, Translational Medicine, Disease Mechanisms, Biomarkers, Immunology, Molecular Medicine, Diagnostics, Therapeutics, Patient Care, Precision Medicine, Clinical Investigation, Medical Innovation, Healthcare Research, Evidence-Based Medicine.

Introduction

Konstantin Konstantinov conducts research emphasizing clinically relevant biomedical investigations that integrate laboratory findings with healthcare applications. His scholarly activities contribute to understanding disease processes, improving diagnostic strategies, and strengthening translational medicine. Indexed publications demonstrate consistent scientific engagement while supporting evidence-driven clinical practice across multidisciplinary healthcare environments.[1]

Research Profile

Konstantin Konstantinov maintains a recognized research profile through Scopus and ORCID, reflecting internationally indexed scholarly contributions. His affiliation with the University of New Mexico supports collaborative medical research, interdisciplinary partnerships, and dissemination of findings within respected scientific journals addressing clinical medicine and biomedical innovation.[2]

Research Contributions

Konstantin Konstantinov contributes to biomedical knowledge through investigations addressing clinical challenges, disease biology, and translational healthcare solutions. His research emphasizes scientific reliability, collaborative methodologies, and practical medical relevance, helping strengthen understanding of therapeutic development while supporting continued advancement of evidence-based clinical medicine internationally.[3]

Publications

Konstantin Konstantinov has authored and co-authored peer-reviewed publications indexed within Scopus, reflecting sustained participation in internationally recognized biomedical literature. His publication portfolio demonstrates scientific consistency, collaborative authorship, and continuing contributions to clinical medicine through research addressing contemporary healthcare questions and translational scientific applications.[1]

Research Impact

Konstantin Konstantinov demonstrates measurable scholarly visibility through internationally indexed publications, citation tracking, and persistent researcher identifiers. His scientific contributions encourage collaboration, knowledge dissemination, and continuing academic influence within clinical medicine while supporting reproducible research standards and responsible advancement of healthcare-related scientific investigation.[2]

Award Suitability

Konstantin Konstantinov demonstrates characteristics aligned with the objectives of the Health Scientists Awards through sustained scholarly productivity, internationally indexed research, interdisciplinary collaboration, and clinically relevant scientific contributions. His academic profile supports consideration for recognition based upon documented research quality, visibility, and professional scientific engagement.[4]

Conclusion

Konstantin Konstantinov represents an active clinical medicine researcher whose internationally indexed publications, institutional affiliation, and commitment to evidence-based biomedical investigation demonstrate meaningful scientific engagement. His documented academic profile provides an appropriate basis for professional recognition within international research award programs supporting healthcare innovation and scientific excellence.[1]

External Links

References

    1. Elsevier. (n.d.). Scopus Author Details: Konstantin Konstantinov, Author ID 55808069944. Scopus.
      https://www.scopus.com/authid/detail.uri?authorId=55808069944
    2. Konstantinov, K. N., Roldan, C. A., & Konstantinov, N. K. (n.d.). Sclerodactyly, tongue telangiectasias, premature severe aortic stenosis, and RNA polymerase III autoantibodies in a patient with syncope.
      https://pubmed.ncbi.nlm.nih.gov/37979901/

    3. Kumar, V., de Saint-Aubain, C. J., & Konstantinov, K. N. (n.d.). A diagnostic odyssey: Mevalonate kinase deficiency revealed by genetic testing in adulthood.

      https://doi.org/10.3390/genes17040439

    4. Health Scientists Awards. (n.d.). Official Awards Website.
      https://healthscientists.org/

Hongguang Nie | Infectious Diseases | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Hongguang Nie
China Medical University

Hongguang Nie
Affiliation China Medical University
Country China
Scopus ID 7103200378
Documents 69
Citations 1143
h-index 17
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-9973-6354

The Innovative Research Award recognizes researchers whose scholarly contributions demonstrate sustained impact within their scientific disciplines. Hongguang Nie of China Medical University has established a notable research profile in infectious diseases through peer-reviewed publications, citation influence, and interdisciplinary collaboration. His research activities have contributed to advancing knowledge related to infectious disease mechanisms, clinical outcomes, epidemiology, and healthcare improvement initiatives. The academic record represented through indexed publications and citation metrics reflects continuing engagement with scientific inquiry and evidence-based healthcare research.[1]

Abstract

Hongguang Nie is a researcher affiliated with China Medical University whose scholarly activities are focused primarily on infectious diseases and related biomedical investigations. His publication portfolio demonstrates engagement with epidemiology, disease mechanisms, clinical research, public health applications, and healthcare outcomes. With a documented record of 69 indexed publications, 1,143 citations, and an h-index of 17, his work has achieved measurable visibility within the scientific community. The breadth of his contributions reflects sustained participation in evidence-based research, interdisciplinary collaboration, and the dissemination of findings that support improved understanding of infectious disease challenges and healthcare advancement.[1]

Keywords

Infectious Diseases, Epidemiology, Clinical Research, Public Health, Disease Prevention, Healthcare Outcomes, Biomedical Science, Medical Research, Infection Control, Translational Medicine

Introduction

Research in infectious diseases remains essential for understanding pathogen transmission, disease progression, prevention strategies, and clinical interventions. Hongguang Nie has contributed to this field through scholarly publications that support evidence-based medical knowledge and healthcare improvement. His research activities align with contemporary priorities in disease control, epidemiology, and public health advancement.[2]

Research Profile

Hongguang Nie is affiliated with China Medical University and maintains an active research profile within infectious diseases. His scholarly record includes peer-reviewed publications indexed in international databases, demonstrating ongoing participation in biomedical research. Citation performance and publication productivity indicate sustained engagement with scientific investigation and collaborative academic endeavors.[1]

Research Contributions

The research contributions of Hongguang Nie encompass infectious disease studies, clinical investigations, healthcare outcome assessments, and epidemiological analyses. His publications have supported understanding of disease-related challenges and informed evidence-based approaches in medical science. Collaborative research efforts further demonstrate his commitment to advancing knowledge through multidisciplinary scientific inquiry.[3]

Publications

The publication record associated with Hongguang Nie includes articles published in recognized scientific journals addressing infectious diseases and related healthcare topics. These works contribute to the dissemination of research findings and facilitate scholarly dialogue. Indexed publications and associated citations reflect the visibility and relevance of his research outputs within the academic community.[1]

Research Impact

Research impact can be evaluated through publication influence, citation metrics, and scholarly engagement. With more than one thousand citations and a measurable h-index, Hongguang Nie’s work demonstrates recognition within relevant research communities. His studies contribute to the broader scientific understanding of infectious diseases and support ongoing developments in healthcare research.[1]

Award Suitability

Hongguang Nie’s scholarly achievements, publication record, citation performance, and research focus in infectious diseases align with the objectives of the Innovative Research Award. His demonstrated commitment to scientific investigation and knowledge dissemination supports consideration for recognition within the Health Scientists Awards framework and related academic evaluation processes.[1]

Conclusion

Hongguang Nie has developed a credible academic profile through sustained contributions to infectious disease research. His publication output, citation record, and engagement in scientific collaboration illustrate continued involvement in advancing medical knowledge. These accomplishments support recognition within academic award programs dedicated to research excellence and healthcare innovation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Hongguang Nie, Author ID 7103200378. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7103200378
  2. Xin, S., Ding, Y., Yu, T., et al. (2025). Mesenchymal Stem Cell-Secreted KGF Ameliorates Acute Lung Injury via the Gab1/ERK/NF-κB Signaling Axis. https://pubmed.ncbi.nlm.nih.gov/40640718/
  3. Li, X., Fu, Y., Yu, T., Song, R., Nie, H., & Ding, Y. (2025). Anti-Oxidant, Anti-Inflammatory and Antiviral Properties of Luteolin Against SARS-CoV-2: Based on Network Pharmacology.     https://pubmed.ncbi.nlm.nih.gov/41011200

Kenjiro Nagai | Infectious Diseases | Research Excellence Award

Published on by Health Scientists

Research Excellence Award

Kenjiro Nagai
Ebino Centro Clinic, Japan

Kenjiro Nagai
Affiliation Ebino Centro Clinic
Country Japan
Scopus ID 56915217000
Documents 20
Citations 585
h-index 12
Subject Area Infectious Diseases
Event Health Scientists Awards
ORCID 0000-0002-7726-7403

Kenjiro Nagai is a researcher affiliated with Ebino Centro Clinic whose scholarly work has contributed to the field of infectious diseases. His publication record, citation performance, and documented research activities demonstrate sustained engagement in clinical and scientific investigations relevant to disease prevention, diagnosis, treatment, and healthcare outcomes. The following article provides a structured overview of his research profile and potential suitability for recognition through the Health Scientists Awards.[1]

Abstract

Kenjiro Nagai has established a research profile centered on infectious diseases and clinically relevant healthcare investigations. His scholarly contributions encompass disease surveillance, patient management strategies, diagnostic evaluation, and evidence-based medical practice. Through a portfolio of peer-reviewed publications and measurable citation influence, his work has supported scientific understanding and practical healthcare applications. The documented research output reflects continuous engagement with contemporary challenges in infectious disease medicine. Bibliometric indicators, including citation performance and h-index, suggest sustained academic visibility. These accomplishments position his research activities as relevant to professional recognition within international scientific and healthcare award frameworks.[1][2]

Keywords

  • Infectious Diseases
  • Clinical Research
  • Disease Prevention
  • Epidemiology
  • Medical Science
  • Patient Care
  • Public Health
  • Health Research

Introduction

The field of infectious diseases remains essential for improving global health outcomes and strengthening healthcare systems. Researchers working within this discipline contribute to understanding disease transmission, treatment approaches, and preventive strategies. Kenjiro Nagai’s scholarly activities align with these objectives through clinically focused investigations and scientific dissemination.[1]

Research Profile

Affiliated with Ebino Centro Clinic in Japan, Kenjiro Nagai has developed a publication record comprising twenty indexed documents. His citation count and h-index indicate continuing academic engagement and recognition within relevant scientific communities focused on infectious diseases and healthcare research.[1]

Research Contributions

His contributions support the advancement of infectious disease knowledge through clinical observations, evidence generation, and publication of findings relevant to patient care. Such efforts contribute to broader scientific understanding and may assist healthcare professionals in informed clinical decision-making processes.[2]

Publications

The documented publication portfolio includes peer-reviewed research articles associated with infectious disease investigations. These works have generated measurable scholarly attention through citations and demonstrate participation in scientific communication, knowledge dissemination, and ongoing engagement with healthcare research topics.[1]

Research Impact

Bibliometric indicators suggest that Kenjiro Nagai’s research has achieved visibility within academic literature. Citation accumulation reflects scholarly use of published findings, while the h-index demonstrates a consistent level of influence across multiple research outputs within the infectious diseases domain.[1]

Award Suitability

Based on available research metrics, publication activity, and subject specialization, Kenjiro Nagai demonstrates characteristics commonly evaluated in scientific recognition programs. His documented contributions to infectious disease research align with the objectives of awards honoring healthcare innovation and scientific advancement.[3]

Conclusion

Kenjiro Nagai’s academic record reflects meaningful engagement in infectious disease research and clinical scholarship. His publication achievements, citation impact, and professional contributions collectively indicate a sustained commitment to advancing medical knowledge and supporting evidence-based healthcare practices.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Kenjiro Nagai, Author ID 56915217000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=56915217000

  2. Nagai, K., Nagai, S., et al. (2025). Report on Successful Treatment of Refractory MAC Lung Disease in Two Elderly Patients with Inhaled Liposomal Amikacin (ALIS) at Half the Standard Dose.

    https://doi.org/10.1016/S1473-3099(20)30154-9

  3. Health Scientists Awards. Award evaluation framework and recognition objectives.https://healthscientists.org/

Ludivine Renaud | Immunology | Best Researcher Award

Published on by Health Scientists

Best Researcher Award

Ludivine Renaud
Medical University of South Carolina, United States

Ludivine Renaud
Affiliation Medical University of South Carolina
Country United States
Scopus ID 15756160300
Documents 28
Citations 677
h-index 17
Subject Area Immunology
Event Health Scientists Awards
ORCID 0000-0002-9300-5032

Ludivine Renaud is affiliated with the Medical University of South Carolina and has contributed to scholarly activities in Immunology research. Her academic profile demonstrates strong publication visibility, citation performance, and sustained scientific engagement. These scholarly achievements align with the recognition standards of the Health Scientists Awards and reflect continued contribution to biomedical and immunological research advancement.[1]

Abstract

Ludivine Renaud has contributed to Immunology research through scientific publications, collaborative investigations, and biomedical research engagement. Her academic profile reflects strong research visibility supported by citation performance and indexed scholarly outputs. The available publication metrics demonstrate sustained participation in immunological and biomedical research activities. Her scholarly achievements align with the recognition standards of the Health Scientists Awards and reflect commitment to advancing scientific understanding through academic collaboration and healthcare-oriented investigations. The combination of publication records, citation impact, and institutional affiliation highlights her contribution to Immunology research and supports broader scientific communication within international biomedical and healthcare research communities globally.[1]

Keywords

  • Immunology
  • Biomedical Research
  • Scientific Publications
  • Citation Analysis
  • Healthcare Innovation
  • Health Scientists Awards

Introduction

Academic recognition within Immunology reflects research contribution, scientific communication, and healthcare-related scholarly engagement. Ludivine Renaud has participated in biomedical and immunological research through publications and collaborative investigations. Her publication visibility and citation performance support recognition within internationally focused healthcare and scientific award programs.[1]

Research Profile

Ludivine Renaud is affiliated with the Medical University of South Carolina and maintains strong scholarly visibility through Scopus-indexed publications and citation-based metrics. Her academic profile includes twenty-eight scientific documents, substantial citation activity, and measurable engagement in Immunology and biomedical research communication activities internationally.[1]

Research Contributions

Her research contributions demonstrate active engagement in Immunology and biomedical sciences through scholarly investigations, collaborative studies, and scientific publication activities. These contributions support scientific communication, healthcare knowledge dissemination, and continued advancement of biomedical research discussions within international healthcare and scientific communities.[2]

Publications

The publication record associated with Ludivine Renaud demonstrates significant participation in scientific dissemination and Immunology research communication. Her indexed scholarly outputs contribute to research accessibility, citation visibility, and institutional representation while supporting biomedical and healthcare-related scientific engagement through peer-reviewed publication activities internationally.[1]

Research Impact

Citation performance and publication visibility indicate measurable scholarly impact within Immunology research.[4] These academic indicators demonstrate sustained engagement in biomedical scientific communication and healthcare knowledge development. The available research metrics reflect continued contribution to biomedical scholarship and support recognition of academic research involvement.[1]

Award Suitability

Ludivine Renaud’s academic profile, publication impact, and biomedical research engagement align with the objectives of the Health Scientists Awards. Her scholarly participation, citation performance, and contribution to Immunology research demonstrate qualities associated with international recognition programs dedicated to healthcare and scientific excellence.[3]

Conclusion

The academic activities of Ludivine Renaud reflect sustained scholarly participation within Immunology through scientific publications, citation visibility, and biomedical research engagement. Her developing research profile and institutional contributions support recognition within academic award frameworks dedicated to healthcare innovation, scientific communication, and biomedical advancement internationally.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Ludivine Renaud, Author ID 15756160300. Scopus.

    https://www.scopus.com/authid/detail.uri?authorId=15756160300
  2. ORCID. (n.d.). ORCID profile record for Ludivine Renaud.

    https://orcid.org/0000-0002-9300-5032
  3. Health Scientists Awards. (n.d.). International healthcare and scientific recognition program.

    Health Scientists Awards
  4. Google Scholar. (n.d.). Google Scholar profile of Ludivine Renaud.

    https://scholar.google.com/citations?user=BDJjEcQAAAAJ&hl=en&oi=ao

Fatemah Alyaqout | Immunology | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Fatemah Alyaqout
Sheikh Jaber Al-Ahmad Al-Sabah Hospital, Kuwait

Fatemah Alyaqout
Affiliation Sheikh Jaber Al-Ahmad Al-Sabah Hospital
Country Kuwait
Google Scholar View Profile
Documents 3
Citations 2
h-index 1
Subject Area Immunology
Event Health Scientists Awards
ORCID 0009-0004-9713-4562

Fatemah Alyaqout is affiliated with Sheikh Jaber Al-Ahmad Al-Sabah Hospital in Kuwait and contributes to research activities within Immunology. Her academic profile demonstrates engagement in scholarly publications, citation-based visibility, and participation in scientific research platforms. These achievements support recognition under the Health Scientists Awards and reflect commitment to advancing healthcare-related academic research.[1]

Abstract

Fatemah Alyaqout has contributed to scholarly activities within Immunology through academic publications and research engagement. Her academic profile reflects participation in healthcare-related scientific studies supported by citation visibility and indexed scholarly records. The available research metrics demonstrate developing academic influence and commitment to scientific advancement. Her research activities support professional recognition within the Health Scientists Awards framework and reflect dedication to evidence-based healthcare research and academic collaboration. The combination of publication activity, institutional affiliation, and scientific participation highlights her emerging contribution to Immunology and healthcare scholarship within regional and international academic communities.[1]

Keywords

  • Immunology
  • Healthcare Research
  • Academic Publications
  • Translational Medicine
  • Medical Research
  • Clinical Studies

Introduction

Academic recognition highlights contributions to scientific advancement, healthcare research, and scholarly communication. Fatemah Alyaqout has participated in Immunology research through academic publications and institutional engagement. Her scholarly activities demonstrate growing academic visibility and support recognition within internationally focused healthcare and scientific award programs.[1]

Research Profile

Fatemah Alyaqout is affiliated with Sheikh Jaber Al-Ahmad Al-Sabah Hospital in Kuwait and maintains scholarly visibility through academic publications and research indexing platforms. Her documented academic metrics include publication records, citations, and an h-index demonstrating participation in healthcare-focused scientific research and scholarly dissemination activities.[1]

Research Contributions

Her research contributions reflect involvement in Immunology-related investigations and healthcare research activities. Scholarly participation through publications and academic collaboration supports ongoing scientific discussions and contributes to the dissemination of healthcare knowledge within professional and academic research environments internationally.[2]

Publications

The publication record associated with Fatemah Alyaqout demonstrates participation in scholarly communication and healthcare-related scientific dissemination. Her indexed academic outputs contribute to citation development and research accessibility while supporting institutional visibility and broader engagement within Immunology and healthcare research communities.[1]

Research Impact

Citation metrics and publication visibility indicate measurable academic engagement within Immunology research. These scholarly indicators support recognition of research participation, scientific communication, and contribution to healthcare knowledge development. The available metrics reflect emerging academic influence and continued involvement in scientific research activities.[1]

Award Suitability

Fatemah Alyaqout’s academic profile, publication activity, and healthcare research participation align with the objectives of the Health Scientists Awards. Her documented scholarly engagement and research visibility demonstrate qualities associated with academic recognition programs dedicated to scientific contribution and healthcare research advancement.[3]

Conclusion

The academic activities of Fatemah Alyaqout reflect participation in Immunology research through scholarly publications, citation visibility, and healthcare-focused scientific engagement. Her developing research profile and institutional contributions support recognition within academic award frameworks dedicated to scientific excellence, healthcare advancement, and scholarly communication.[1]

References

  1. Google Scholar. (n.d.). Google Scholar profile of Fatemah Alyaqout.

    https://scholar.google.com/citations?user=ZsYuZJsAAAAJ&hl=en&oi=ao
  2. ORCID. (n.d.). ORCID profile record for Fatemah Alyaqout.

    https://orcid.org/0009-0004-9713-4562
  3. Health Scientists Awards. (n.d.). International healthcare and scientific recognition program.

    Health Scientists Awards

Saif Jabbar yasir | Virology | Editorial Board Member

Published on by Health Scientists

Editorial Board Member

Saif Jabbar yasir — University of Kufa
Saif Jabbar yasir
Researcher Saif Jabbar yasir
Affiliation University of Kufa
Country Iraq
Scopus ID 57212479777
Documents 15
Citations 12
h-index 2
Subject Area Virology
Event Health Scientists Awards
ORCID 0000-0002-0193-0643

Saif Jabbar yasir is associated with the University of Kufa in Iraq and has contributed to academic activities in the field of virology through scholarly publications, editorial participation, and interdisciplinary scientific engagement. His profile reflects continued involvement in health-related scientific communication and research dissemination, particularly within the broader framework of biomedical and virological studies.[1] The recognition connected to the Health Scientists Awards highlights participation in international academic networks focused on scientific advancement, research visibility, and editorial collaboration.[2]

Abstract

Saif Jabbar Yasir is affiliated with the University of Kufa, Iraq, and is associated with scientific activities in virology and biomedical research. His academic profile includes Scopus-indexed publications, citation activity, and participation in scholarly communication through editorial and research-related contributions.[3]  The profile demonstrates involvement in international scientific visibility systems including ORCID and Scopus, supporting transparency in publication and author identification. Editorial participation and research dissemination activities reflect engagement with contemporary health science and infectious disease discussions. Recognition connected with academic award frameworks further highlights contributions to scientific communication, publication ethics, and interdisciplinary collaboration within the broader biomedical and health sciences community internationally.[1] 

Keywords

  • Virology
  • Biomedical Research
  • Health Sciences
  • University of Kufa
  • Public Health

Introduction

Academic editorial participation supports scientific communication through peer review, manuscript evaluation, and dissemination of validated research. Researchers involved in editorial activities contribute to maintaining scholarly integrity and accessibility across international scientific communities.[2] University of Kufa researcher Saif Jabbar Yasir demonstrates engagement in virology-related publishing, indexed scholarly publications, and transparent academic research dissemination.[1] 

Research Profile

Saif Jabbar Yasir’s research profile reflects involvement in virology and biomedical sciences through Scopus-indexed publications, citation activity, and international academic visibility.[1] Affiliated with University of Kufa, his scholarly presence is supported by ORCID and Scopus identification systems, enabling verification of research contributions, publication records, and interdisciplinary scientific engagement.[4]

Research Contributions

Research contributions associated with Saif Jabbar Yasir include participation in virology-related scientific publication, biomedical communication, and editorial activities.[5] Indexed scholarly outputs contribute to research dissemination, interdisciplinary collaboration, and scientific visibility. Academic involvement reflects engagement with infectious disease research, peer-review processes, and broader biomedical knowledge integration within international publication systems.[2]

Publications

The publication record associated with Saif Jabbar Yasir demonstrates involvement in scholarly dissemination and indexed academic communication. Scopus-indexed documents contribute to citation tracking, publication visibility, and interdisciplinary biomedical research recognition.[6] Integration with ORCID and international indexing databases supports transparent academic identification, verification of publications, and scientific dissemination activities globally.[2]

Research Impact

Research impact associated with Saif Jabbar Yasir may be observed through citation indicators, indexing visibility, editorial engagement, and participation in scholarly communication. Citation activity within Scopus reflects measurable scientific interaction.[1]  Editorial participation additionally contributes to maintaining publication standards, facilitating peer-reviewed dissemination, and supporting international academic networking within biomedical research communities.[2]

Award Suitability

The academic profile of Saif Jabbar Yasir aligns with criteria commonly considered in scientific recognition programs, including indexed publications, editorial engagement, and research visibility.[2] Participation in scholarly communication and peer-review activities reflects familiarity with publication ethics and scientific evaluation, supporting suitability for international academic recognition and editorial collaboration initiatives.[5]

Conclusion

Saif Jabbar yasir represents an academic profile connected to virology, scientific publication activities, and editorial participation through the University of Kufa in Iraq. Indexed research visibility, citation tracking, and editorial engagement collectively contribute to scholarly recognition within contemporary biomedical research environments.[2] The profile demonstrates ongoing involvement in international academic communication systems and reflects participation in scientific dissemination initiatives associated with health science advancement.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Saif Jabbar yasir, Author ID 57212479777. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57212479777
  2. Health Scientists Awards. (n.d.). International academic recognition and editorial participation guidelines.
    Health Scientists Awards
  3. ORCID. (n.d.). ORCID researcher identifier profile.
    https://orcid.org/0000-0002-0193-0643
  4. ResearchGate. (n.d.). ResearchGate profile of Saif Jabbar yasir .
    https://www.researchgate.net/profile/Saif-Yasir
  5. Google Scholar. (n.d.). Scholar profile of Saif Jabbar yasir .
    https://scholar.google.com/citations?user=Rwt7a2MAAAAJ&hl=en&oi=ao

  6. Alattraqchi, A., Yasir, S. J., Abdul Jaleel, A.-K. K., & Hassoun, H. K. Association between human herpesvirus 6 infection and inflammasome NLRP3 gene expression in multiple sclerosis Iraqi patients.

    https://link.springer.com/article/10.1186/s41983-025-01040-w